GPLC GlycoCarn® with CoQ10 is a food supplement based on GPLC (Glycine Propionyl-L-Carnitine) that is a heart-specific carnitine that supports arterial blood flow.

GlycoCarn® is a registered trademark of Sigma-Tau Health Science Inc. It is the only scientifically validated and protected source in the United States Patent No. 6703042 and EP1202956, respectively, of the active nitrogen oxide, the stimulating dipeptide, glycine propionyl L-carnitine hydrochloride (GPLC); a propionyl ester of the positively charged nitrogen-containing ion, L-carnitine, molecular unit with the ambivalent amino acid, glycine.

Properties :

► Increases nitric oxide (NO)

► Accelerated recovery

► Improved performance

► Supports arterial blood flow

► Clinically tested propionyl-L-carnitine for heart health

► Powerful antioxidant

► Remove free radicals

► Assists in producing energy

► Protects against lipid peroxidation

► Facilitate the use of fat for energy

Method of administration: As a dietary supplement, take 2-6 capsules daily, preferably with the main meals. To increase physical performance on training day, all 6 capsules (4.5g dose administered and in product studies) can be taken 30-60 minutes before training. It can be combined with nitric oxide precursors such as citrulline, beta-alanine or arginine to maximize muscle mass.

Nutrition Information per 2 capsules:

GlycoCarn (Glycine Propionyl-L-Carnitine HCl) 1516 mg

Propionyl-L-Carnitine (PLC) 1000 mg

Glycine 348 mg

Coenzyme Q10 (CoQ10) 60 mg

The studies underpinning GlycoCarn® as an antioxidant and NO last generation amplifier:

1> Bloomer, RJ; Tschume, LC; Smith, WA (2009). "Glycine propionyl-L-carnitine modulates lipid peroxidation and nitric oxide in human subjects". Int J Vitam Nutr Res. 79 (3): 131-141. doi: 10.1024 / 0300-9831.79.3.131.

2> Bloomer, RJ; Smith, WA; Fisher-Wellman, KH (2007). "Glycine propionyl-L-carnitine increases plasma nitrate / nitrite in resistance trained men". J Int Soc Soc Nutr. 4 (1): 22. doi: 10.1186 / 1550-2783-4-22.

3> Malyshev, VV; Oshchepkova, OM; Seminokii, IZH; Nefedova, TV; Morozona, TP (1996). "The limitation of lipid hyeroxidation and the prevention of stressor damage to the heart by glycine derivatives". J Exp Clin Pharmocol. 59: 23-25.

4> Reznick, AZ; Kagan, VE; Ramsey, R. (1992). "Antiradical effects in L-propionyl carnitine protection of the heart against ischemia-reperfusion injury: the possible role of iron chelation". Arch Biochem Biophys. 296: 394-401. doi: 10.1016 / 0003-9861 (92) 90 589 a.

5> Smith, WA; Fry, AC; Tschume, LC; Bloomer, RJ (2008). "Effect of glycine propionyl-L-carnitine on aerobic and anaerobic exercise performance". Int J Sport. Nutr Exerc Metab. 18 (1): 19-36.

6> Jacobs, PL; Goldstein, ER; Blackburn, W; Orem, I; Hughes, JJ. "GPLC produces enhanced anaerobic work capacity with reduced lactate accumulation in resistance trained males". J Int Soc Soc Nutr. 6 (9).

7> "Effect of glycine propionyl-L-carnitine on aerobic and anaerobic exercise performance". Int J Sport Nutri Exerc Metab. 18 (1): 19-36. Feb 2008

WARNINGS

Food supplements should not be used as a substitute for a balanced and varied diet and a healthy lifestyle. Do not exceed the stated recommended daily dose. Keep out of reach of young children. Store tightly closed in a cool and dry place.